A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth

Recruiting now · Not applicable

Conditions studied: Androgenic Alopecia

In brief

The goal of this clinical study is to evaluate the efficacy and safety of the Ultra device for the treatment of hair regrowth by assessing the improvement of hair density and hair shaft diameter.

Key facts

Study ID

NCT07588243

Run by

CynosureLutronic

People needed

44

Starts

2026-02-19

Expected to finish

2026-12-01

Last updated by the study team

2026-05-27

Who can join

Age: 22 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 22 - 70 years old
• Is willing to undergo study device use.
• Fitzpatrick skin type I-VI
• Clinical diagnosis of androgenetic alopecia (Norwood-Hamilton II-V or Ludwig I-II)
• Willing to avoid significant changes to hair (such as drastic haircuts and dying hair) during their involvement in the study.
• Willing to maintain current diet and exercise routine throughout study duration.
• Understands and accepts the study condition to not receive any other procedures to the treatment area or to undergo any procedures, take any medications, supplements, or partake in any other treatments indicated for hair growth throughout the length of the study.
• Understands and accepts the study condition of and agrees that he or she is able to be present for all study visits.
• Willing to comply with all requirements of the study and is able to provide written informed consent.

You may not qualify if…

• Is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding, or planning a pregnancy during the study period.
• Has a diagnosis of other forms of alopecia (e.g., scarring alopecia, alopecia areata)
• Has recent use (within 6 months) of a systemic hair growth medications (e.g., oral finasteride).
• Inconsistent use of vitamins that can affect hair growth - must have stabilized use for at least 6 months prior to first treatment.
• Had previous treatment (such as laser or topical) to scalp within 6 months.
• Has a malignant disease, cancer, or uncontrolled medical condition.
• Has an impaired immune system due to immunosuppressive diseases, such as AIDS and HIV, or use of immunosuppressive medications

Where it is running

• Dy Dermatology — Glenview, Illinois, United States (enrolling)
• Cynosure Lutronic — Westford, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.